{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:18Z","timestamp":1788532038110,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Baoding Science and Technology Plan Project","award":["2341ZF145"],"award-info":[{"award-number":["2341ZF145"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:p>\n                    Mild obstructive sleep apnea (OSA) is often underdiagnosed but contributes to treatment-resistant hypertension through oxygen deprivation and activation of the renin\u2013angiotensin\u2013aldosterone system. Spironolactone, an aldosterone antagonist, may help manage both hypertension and OSA-related symptoms. This study aims to evaluate the effectiveness and safety of spironolactone in patients with mild OSA and resistant hypertension. This retrospective observational cohort study included 96 patients diagnosed with mild OSA and resistant hypertension between December 2022 and October 2023. Patients were grouped according to whether they received spironolactone (20\u2009mg\/day) in addition to conventional antihypertensive treatment. Outcomes included blood pressure (office, ambulatory, and daytime), apnea-hypopnea index (AHI), lowest oxygen saturation (SaO\n                    <jats:sub>2<\/jats:sub>\n                    ), and biochemical parameters (blood urea nitrogen [BUN], potassium, sodium, and creatinine). Missing data were handled using multiple imputation. After 12 weeks, the spironolactone group showed greater reductions in blood pressure compared with the control group: office systolic blood pressure (OSBP) decreased by 5.75\u2009mm Hg (95% CI: \u22128.84 to \u22122.66) and office diastolic blood pressure (ODBP) decreased by 3.67\u2009mm Hg (95% CI: \u22126.46 to \u22120.88). The AHI improved by 1.85 events\/hour (95% CI: \u22123.23 to \u22120.47), and SaO\n                    <jats:sub>2<\/jats:sub>\n                    increased by 3.33% (95% CI: 0.93\u20135.73). No cases of hyperkalemia or clinically significant kidney dysfunction were observed, and the treatment was well tolerated. Spironolactone was associated with improved blood pressure control and modest improvements in sleep-related parameters in patients with mild OSA and resistant hypertension, with a favorable short-term safety profile. The small sample size and relatively young cohort limit the generalizability of the findings.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048755","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:01:48Z","timestamp":1778896908000},"page":"e48755","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Spironolactone therapy in resistant hypertension comorbid with mild obstructive sleep apnea: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"given":"Chao","family":"Fang","sequence":"first","affiliation":[{"name":"Geriatrics Department, Hebei University Affiliated Hospital, Baoding, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Hebei University Affiliated Hospital, Baoding, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Geriatrics Department, Hebei University Affiliated Hospital, Baoding, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Geriatrics Department, Hebei University Affiliated Hospital, Baoding, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8896-2031","authenticated-orcid":false,"given":"Simin","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei University Affiliated Hospital, Baoding, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/HP.S103091","article-title":"Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach.","volume":"4","author":"Sforza","year":"2016","journal-title":"Hypoxia (Auckl)"},{"key":"R2-20260904","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsmc.2016.05.002","article-title":"Consequences of obstructive sleep apnea: cardiovascular risk of obstructive sleep apnea and whether continuous positive airway pressure reduces that risk.","volume":"11","author":"Khayat","year":"2016","journal-title":"Sleep Med Clin"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"11990","DOI":"10.1038\/s41598-021-91329-6","article-title":"Association between nocturnal activity of the sympathetic nervous system and cognitive dysfunction in obstructive sleep apnoea.","volume":"11","author":"Alomri","year":"2021","journal-title":"Sci Rep"},{"key":"R4-20260904","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/HYPERTENSIONAHA.116.08324","article-title":"Sympathetic activity, hypertension, and the importance of a good night\u2019s sleep.","volume":"68","author":"Biaggioni","year":"2016","journal-title":"Hypertension"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1152\/japplphysiol.00315.2015","article-title":"Sympathoexcitation and arterial hypertension associated with obstructive sleep apnea and cyclic intermittent hypoxia.","volume":"119","author":"Weiss","year":"2015","journal-title":"J Appl Physiol (1985)"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.3390\/jcm13247603","article-title":"Objective approach for titration of continuous positive airway pressure in patients with obstructive sleep apnea using daytime continuous positive airway pressure titration based on respiratory movement regularity.","volume":"13","author":"Burioka","year":"2024","journal-title":"J Clin Med"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12890-023-02612-3","article-title":"Long term adherence to continuous positive airway pressure in mild obstructive sleep apnea.","volume":"23","author":"Qiao","year":"2023","journal-title":"BMC Pulm Med"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"100475","DOI":"10.1016\/j.ajpc.2023.100475","article-title":"Management of hypertension in obstructive sleep apnea.","volume":"13","author":"Ou","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"R9-20260904","first-page":"24","article-title":"Chinese guidelines for the prevention and treatment of hypertension (2018 revised edition).","volume":"24","year":"2019","journal-title":"Chin J Cardiovasc Med"},{"key":"R10-20260904","first-page":"21","article-title":"Guideline for primary care of adult obstructive sleep apnea (2018).","volume":"18","year":"2019","journal-title":"Chin J Gen Pract"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"111967","DOI":"10.1016\/j.mce.2023.111967","article-title":"Mineralocorticoid receptor blockade protects the kidneys but does not affect inverted blood pressure rhythm in hypertensive transgenic (mRen-2)27 rats.","volume":"572","author":"\u0160utovsk\u00e1","year":"2023","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl 3","key":"R12-20260904","first-page":"e36","article-title":"Evaluation of the efficacy and safety of medical treatment with lower doses of spironolactone in a cohort of patients with primary aldosteronism.","volume":"41","author":"Sconfienza","year":"2023","journal-title":"J Hypertens"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"364","DOI":"10.18705\/1607-419X-2024-2393","article-title":"New drugs for the treatment of resistant hypertension: nonsteroidal mineralocorticoid receptor antagonist finerenone and aldosterone synthase inhibitor baxdrostat.","volume":"30","author":"Kuzmin","year":"2024","journal-title":"\u201cArterial\u2019naya Gipertenziya\u201d (\u201cArterial Hypertension\u201d)"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"zsae296","DOI":"10.1093\/sleep\/zsae296","article-title":"Mineralocorticoid receptor antagonism prevents coronary microvascular dysfunction in intermittent hypoxia independent of blood pressure.","volume":"48","author":"Badran","year":"2025","journal-title":"Sleep"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1097\/01.hjh.0000523888.76924.ae","article-title":"[PP.25.23] Factors influencing resistance to drug therapy in patients with essential hypertension.","volume":"35","author":"Bezrodna","year":"2017","journal-title":"J Hypertens"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"56","DOI":"10.22270\/ajprd.v12i6.1494","article-title":"Aldosterone-to-renin ratio as a diagnostic and prognostic marker in resistant hypertension: insights from a retrospective observational study on age, hormonal dysregulation, and anthropometric correlates.","volume":"12","author":"Choudhary","year":"2024","journal-title":"Asian J Pharm Res Dev"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1097\/01.hjh.0000548206.82989.e8","article-title":"A8669 vascular stiffness in true resistant hypertensive patients after renal denervation.","volume":"36","author":"Ionov","year":"2018","journal-title":"J Hypertens"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fmed.2017.00256","article-title":"Fluid redistribution in sleep apnea: therapeutic implications in edematous states.","volume":"4","author":"da Silva","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"108875","DOI":"10.1016\/j.pharmthera.2025.108875","article-title":"Management of drug-resistant hypertension as a heterogeneous disorder.","volume":"271","author":"Tabrizchi","year":"2025","journal-title":"Pharmacol Ther"},{"key":"R20-20260904","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201504-0754ED","article-title":"A brief history of fluid and sleep.","volume":"191","author":"Kent","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-20260904","first-page":"49","article-title":"Effectiveness of spirolactone on the treatment of laryngeal edema and complications after H-uvulopalatopharyngoplasty for patients with obstructive sleep apnea.","volume":"34","author":"Tang","year":"2020","journal-title":"J Clin Otorhinolaryngol Head Neck Surg"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"111780","DOI":"10.1016\/j.exger.2022.111780","article-title":"Chronic intermittent hypoxia induces renal fibrosis through MR activation.","volume":"163","author":"Zhang","year":"2022","journal-title":"Exp Gerontol"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"zsaa228","DOI":"10.1093\/sleep\/zsaa228","article-title":"Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin-angiotensin-aldosterone system activity in humans with obstructive sleep apnea.","volume":"44","author":"Nicholl","year":"2021","journal-title":"Sleep"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/08037051.2021.1880881","article-title":"A systematic review and meta-analysis of effects of spironolactone on blood pressure, glucose, lipids, renal function, fibrosis and inflammation in patients with hypertension and diabetes.","volume":"30","author":"Lin","year":"2021","journal-title":"Blood Press"},{"issue":"Suppl 3","key":"R25-20260904","doi-asserted-by":"crossref","first-page":"gfaa139.SO033","DOI":"10.1093\/ndt\/gfaa139.SO033","article-title":"SO033 Patiromer to enable spironolactone in patients with resistant hypertension and chronic kidney disease (AMBER): prespecified results by baseline serum potassium.","volume":"35","author":"Rossignol","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/hr.2015.129","article-title":"Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism.","volume":"39","author":"Karashima","year":"2016","journal-title":"Hypertens Res"},{"key":"R27-20260904","doi-asserted-by":"crossref","first-page":"bvab144","DOI":"10.1210\/jendso\/bvab144","article-title":"Tolerability and efficacy of long-term medical therapy in primary aldosteronism.","volume":"5","author":"Tang","year":"2021","journal-title":"J Endocr Soc"},{"key":"R28-20260904","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/dom.16037","article-title":"Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease: an observational follow-up of the PRIORITY study.","volume":"27","author":"Wasehuus","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"R29-20260904","doi-asserted-by":"crossref","first-page":"ehae666.1055","DOI":"10.1093\/eurheartj\/ehae666.1055","article-title":"The safety of in-hospital initiation of SGLT2 inhibitor with MRA therapy in patients hospitalized for heart failure with a reduced left ventricular ejection fraction and chronic kidney disease.","volume":"45","author":"Obertynska","year":"2024","journal-title":"Eur Heart J"},{"issue":"10 Pt 1","key":"R30-20260904","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.36740\/WLek202110117","article-title":"The effect of spironolactone on serum electrolytes and renal function tests in patients with severe chronic heart failure.","volume":"74","author":"Almedeny","year":"2021","journal-title":"Wiad Lek"},{"issue":"Suppl 1","key":"R31-20260904","first-page":"10114","article-title":"Abstract 10114: a systematic review, meta-analysis of sham and placebo controlled trials testing spironolactone and renal denervation as treatments for resistant hypertension.","volume":"146","author":"Ahmed","year":"2022","journal-title":"Circulation"},{"key":"R32-20260904","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3390\/ijms24032245","article-title":"Cardiovascular disease in obstructive sleep apnea: putative contributions of mineralocorticoid receptors.","volume":"24","author":"Badran","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R33-20260904","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s11325-024-03113-1","article-title":"Atomoxetine and spironolactone combine to reduce obstructive sleep apnea severity and blood pressure in hypertensive patients.","volume":"28","author":"Schwartz","year":"2024","journal-title":"Sleep Breath"},{"key":"R34-20260904","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/HJH.0000000000003144","article-title":"Prevalence and associated factors of obstructive sleep apnea in refractory hypertension.","volume":"40","author":"Chedier","year":"2022","journal-title":"J Hypertens"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:01:48Z","timestamp":1788530508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":34,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048755","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2025-09-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}